why choose us

First received: May 09, 2023

Clinical Trial: A Study to Evaluate Pharmacokinetics (PK) and Safety of Inaxaplin in Participants With Renal Impairment

Study Status: Completed

Recruit Status: RECRUITING

Condition: Renal Impairment

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-label Study Evaluating the Pharmacokinetics and Safety of a Single Dose of Inaxaplin in Subjects With Severe Renal Impairment and Healthy Subjects With Normal Renal Function

Brief Summary: The purpose of this study is to evaluate the pharmacokinetics and safety of a single dose of Inaxaplin (IXP) in participants with severe renal impairment and healthy participants with normal renal function.

Read more